Related Experiment Video
Updated: Feb 22, 2026
06:58
Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.9K
Armed and Aging: Dementia and Firearms Do Not Mix !
Gabriele Cipriani1,2, Sabrina Danti1, Cecilia Carlesi1
1a Department of Psychiatry , Versilia Hospital , Lido di Camaiore , Italy.
Journal of Gerontological Social Work
|September 21, 2017
Summary
Dementia patients possessing firearms poses a significant risk. Healthcare professionals must collaborate to evaluate these individuals and prevent firearm-related violence.
Area of Science:
- Public Health
- Neurology
- Forensic Science
Background:
- The presence of firearms among individuals with dementia is a growing concern.
- Limited research exists, primarily case reports, on dementia patients owning firearms.
- Firearm-related violence prevention necessitates identifying at-risk individuals.
Purpose of the Study:
- To highlight the risks associated with firearm ownership in dementia patients.
- To emphasize the need for collaborative healthcare professional evaluations.
- To prevent firearm-related injuries and harm in individuals with dementia.
Main Methods:
- Review of existing literature and case reports.
- Analysis of the role of healthcare professionals in risk assessment.
- Discussion of preventative strategies for firearm access.
Main Results:
- Dementia patients may pose a risk of firearm-related violence.
- Interdisciplinary collaboration among healthcare professionals is crucial.
- Proactive identification and intervention are needed to mitigate risks.
Conclusions:
- Healthcare professionals, including physicians and social workers, must work together.
- A comprehensive evaluation process for dementia patients is essential.
- Preventing firearm access can avert serious injuries and irreparable harm.
Related Concept Videos
01:30Dementia
597
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
597
01:15Drug Dosing: Geriatric Patients
308
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
287
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287
01:26Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
750
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
750